PulseAugur
EN
LIVE 16:59:14
中文(ZH) 步长制药：控股子公司参与国家科技重大专项艾滋病疫苗研发项目

36Kr reports on Bu Chang Pharmaceutical's subsidiary joining AIDS vaccine research

By PulseAugur Editorial · [1 sources] ·

Bu Chang Pharmaceutical's subsidiary, Zhejiang Tianyuan, has been selected to participate in a national science and technology major project focused on developing an AIDS vaccine. The project involves the production and initial clinical trial application for the vaccine. Separately, *ST Wentai is dealing with ongoing legal challenges regarding its control over its subsidiary, Amkor Semiconductor, following a ruling from the Amsterdam Court of Appeal. AI

RANK_REASON The cluster contains information about participation in a national science and technology project for vaccine development, which falls under research. [lever_c_demoted from research: ic=1 ai=0.1]

Read on 36氪 (36Kr) →

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →

36Kr reports on Bu Chang Pharmaceutical's subsidiary joining AIDS vaccine research

How we ranked this

Signal score
0 / 100
Composite score across the factors below. Higher = stronger signal that this story matters right now.
Newsworthiness bucket
Tool
The cluster contains information about participation in a national science and technology project for vaccine development, which falls under research. [lever_c_demoted from research: ic=1 ai=0.1]
Source corroboration
Single-source cluster
Only one publisher covered this so far. Single-source stories can still rank when the publisher is high-authority, but they lack cross-source corroboration.
Topics
other
Editorial topic classification. Feeds into how the story surfaces on /topic/<slug> hub pages and into the per-entity coverage mix.
AI-industry relevance
Low
Off-topic or adjacent — cluster remains reachable but doesn't surface in AI-industry rankings.
Story freshness
116 days old
Aged out of breaking-news scoring windows; ranking reflects the durable signal from the full source set.

Full methodology in our editorial standards.

COVERAGE [1]

  1. 36氪 (36Kr) TIER_1 中文(ZH) ·

    Buchang Pharma: Controlling subsidiary participates in the national major science and technology special AIDS vaccine R&D project

    36氪获悉，步长制药公告，公司控股子公司浙江天元近日收到国家卫生健康委下发的《关于新发突发与重大传染病防控国家科技重大专项2026年度项目立项的通知》，浙江天元参与“多功能抗体预防性艾滋病疫苗研发”项目，课题为艾滋病疫苗的生产和I期临床申报。

RELATED TOPICS